Several changes are taking place in the pharmaceutical industry, in order to improve efficiency and reduce cost, besides several drug developments and testing. High rate of attrition in drug development in the last two decades, especially when the drug reaches the later stages of development, is a major concern for the pharmaceutical industry. As a result, the heavy cost on research and development is incurred exceedingly on the pharmaceutical company. Thus, the pharmaceutical industry is constantly in the need of finding reasons for attrition failures.
However, the adoption of in vitro ADME screening into drug discovery programs have reduced this drug failure up to an extent. In 1991, 40% of clinical trial failures were due to poor pharmacokinetics. By, 2000 this number was reduced to 10% and this happened with the advent of in vitro ADME. In vitro ADME has been widely accepted in the pharmaceutical industry and its value has been recognized in the last five years. Some new cellular models and techniques have expanded the market of in vitro toxicology and this market is expected to grow a CAGR of 15.3% from 2013 to 2018. The later stage attrition can be overcome by the advent and subsequent growth of the in vitro toxicology testing methods.
There are several advantages of the in vitro toxicology approach as it has improved the overall predictive quality because human cells are being used. Moreover, this method is cost effective and is less time consuming as compared to the animal testing methods. Earlier, the methods for predicting toxicity in humans were same for testing toxicity in animals, but there are many chemicals that are toxic to one and non toxic to another and vice versa. It creates a lot more confusion in the testing and development of new drugs. Thus, the testing that is been conducted on human cells gives better opportunity to understand and improve the predictions of toxicity in humans. Thus, these in vitro toxicology methods are likely to gain more importance in the forecasted period with the continuous advancements in technology.
Download Complete PDF Brochure:
Vitro Toxicity Testing Market: Key Segments
This report covers global In vitro toxicity testing market along with their types and packaging. It also covers the performance of In vitro toxicity testing types and application in different regions of the world namely, North America, Europe, Asia and RoW (Rest of the World) along with their sub-segments. Moreover, the report provides in-depth analysis of In vitro toxicity testing types and application with their market estimated and forecast from 2011 to 2018, along with their compound annual growth rate from 2013 to 2018.
The application of cosmetics and household industry, pharmaceutical industry, food industry and chemical industry has been covered in this report providing their market estimates and forecast from 2011 to 2018. Furthermore, the three main segments of In vitro toxicity testing, i.e., by application, by type and by end use in detail, are covered with their sub segment break down. Under the In vitro toxicity testing type segment, market estimations have been included for In vitro toxicity testing by absorption, by dose and by toxic substances with their sub-segments. The detailed analysis of these segments along with their estimates and forecast has been provided in this report. The drivers, restraints and opportunities concerning the In vitro toxicology testing market have been thoroughly covered in this report along with their impact analysis and this would be highly helpful in taking corporate strategic decisions related to In vitro toxicity testing market.
This report also provides company profiles of the major players in this industry. Our company profile includes company and financial overview, business strategies adopted by the companies, SWOT analysis and their recent developments which can help in assessing the competition in the market. Some of the major companies included in this report include Accelrys Software Inc., Apredica (Acquired By Cyprotex), Bio-Rad Laboratories, Charles River,Laboratories International Inc., Covance Inc., Gene Logic Inc., In Vitro Technologies, Mattek Corporation, Molecular Toxicology Inc., MB Research Laboratories, RTI Health Solutions, SBW Ltd., Xenobiotic Detection Systems (XDS) and Xenometrix.
Browse Full Research Report :
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
Browse market research blog: